Jan 22, 2018 - With earnings surprises well in the cards, the healthcare sector is expected to witness earnings growth of 3% in the fourth quarter, suggesting some upside for healthcare ETFs.
Jan 22, 2018 - Keep your eyes on these three drugmakers.
Jan 22, 2018 - Reviews five stock evaluation systems.Offers a potential alternative and outlines its advantages.Demonstrates, through backtests, its effectiveness.Names the stocks it favors today.
Jan 22, 2018 - Merck (MRK), announces first time results from the phase II study evaluating the use Keytruda in patients with advanced hepatocellular carcinoma (HCC), previously treated with sorafenib.
Jan 21, 2018 - Which stock wins in a head-to-head match-up between the big biotech and the big pharma company?
Jan 21, 2018 - Olaparib is finally approved in Japan as maintenance.Merck and Macrogenics look to salvage hopes of pembro in gastric cancer.Pfizer and Gilead mark a big CAR-T cell collab.
Jan 21, 2018 - If you want to support women in the workplace, the right portfolio strategy can back that up.
Jan 21, 2018 - Strong free cash flow allows Pfizer to return a significant amount of capital back to shareholders through dividends (3.66% annual yield) and share repurchases.Pfizer's stock trades at a discount base
Jan 20, 2018 - Amgen stacks the deck on multiple myeloma.Pfizer and Foundation Medicine partner up for companion diagnostics.Novartis on the precipice of another biosimilar approval.
Jan 19, 2018 - Kite, a Gilead Company (GILD), announced that it inked a clinical trial collaboration with Pfizer, for combination study.